
Switches on your body's "Master Regulator" of cellular defense, governing over 200 protective genes to neutralize toxins at the source.
Daily use for at least 6 weeks helps build gut health and support regularity. Stick with it and see the difference!
Specifically formulated to address the dormant Stem Cells responsible for recurrence that conventional treatments often miss.
For years, survivors have lived in the shadow of "scanxiety," searching for a way to ensure the "next shoe" never drops. The challenge isn't just about eating right; it’s about maintaining a biological environment where cells cannot thrive. Standard broccoli pills often fail because they lack the "spark" of live enzymes, leaving your protection up to chance.
At MoreLife, we utilize a stabilized, dual-action formula that provides a "chemo-protective shield". By activating the Nrf2 pathway, our complex works long after treatment ends to re-activate tumor-suppressor genes and target the cancer stem cells responsible for relapse.
Rated 4.8/5 By 50,000 Happy Customers
Sulforaphane has been studied alongside multiple chemotherapy agents including paclitaxel, cisplatin, doxorubicin, and 5-fluorouracil, demonstrating synergistic rather than antagonistic effects. That said, every patient's protocol is different. We strongly recommend discussing supplementation with your oncologist or integrative medicine provider before use during active treatment.
Sulforaphane modulates Cytochrome P450 enzymes (CYP1A2 and CYP3A4), which are involved in drug metabolism. This is why transparency with your care team matters. In most studied cases, this interaction supports rather than undermines treatment — but your oncologist should be aware of everything you're taking.
Yes. Sulforaphane is one of the most researched phytochemicals in modern medicine, with over 125 clinical trials and thousands of peer-reviewed studies documenting its effects on Nrf2 activation, HDAC inhibition, cancer stem cell targeting, and chemosensitization. The stabilized formulation we use has been selected for use in human clinical trials at institutions including Johns Hopkins.
Most oncologists are trained in pharmacological interventions, not nutritional biochemistry. Sulforaphane also cannot be patented in its natural form, which limits the financial incentive for large-scale pharmaceutical promotion. The research exists — it simply hasn't made its way into standard oncology practice yet. Many integrative oncologists and functional medicine practitioners are already recommending it.